Azithromycin and the risk of death
Leo Sher, M.D. The U.S. Food and Drug Administration (FDA) has notified healthcare professionals of a new study (1) reporting a small increase in cardiovascular death, and in the risk of death from any cause, in patients treated with a 5-day course of azithromycin (Zithromax; Pfizer) compared to individuals treated with amoxicillin, ciprofloxacin, or no […]
